Tony Huge

Cardio Doesn’t Lower Cholesterol the Way You Think: Tony Huge’s Video Guide

Table of Contents

Cardio lowers LDL by about half a point. That is the average across 31 trials and 1,800 people, and it is the number Tony Huge builds this whole video around. Exercise is a triglyceride drug, it nudges HDL, and it barely touches the particle count that actually drives heart disease. Tony goes through the trial data, the timing trap in your blood draw, walking versus jogging, and the so-called exercise mimetics, then explains why he still thinks exercise protects the heart anyway.

Video: Cardio Doesn’t Lower Cholesterol the Way You Think. Published September 16, 2026. Watch on YouTube.

What the video covers

Exercise is a triglyceride drug

The opening claim is deliberately blunt. Tony cites a pooled analysis of 31 trials in 1,800 people where cardio lowered LDL by half a point, and a larger set of 49 trials where triglycerides fell about 9%, total cholesterol 2%, HDL rose 2%, and LDL fell 3%, which he calls close to nothing. If someone has been doing cardio for six months to fix their LDL and the number did not move, that is the expected result, not a failure of effort.

So the question becomes whether triglycerides deserve the attention LDL gets. Tony’s answer is a careful no. People born with a broken copy of APOC3 run triglycerides 39% lower for life and have 40% less heart disease. A second population showed 44% lower triglycerides and 36% less disease. But when drug companies tried to buy that result with a pill, it did not work: a drug that cut triglycerides 26% in 10,497 diabetics produced 572 events versus 560 on placebo; a fibrate on top of a statin in 5,518 people gave 2.2% a year versus 2.4%; four grams of fish oil in 13,078 people gave 12% versus 12.2% and the trial was stopped. The one fish oil trial that won used mineral oil as the placebo, and the placebo group got worse.

Why ApoB is the number that matters

Tony ties it together with the particle count. ApoB is the number of particles carrying fat around. Genes that lower triglycerides and genes that lower LDL produce the same drop in heart disease as long as they drop ApoB by the same amount. Lower the count and you win. Drain the fat out of the particles and leave the count alone, and you get what those drug trials got. The one place lowering triglycerides pays regardless is the pancreas: under 200, about eight people in 10,000 have a pancreatitis attack per year; over 1,000, it is 121.

“Exercise cuts the numbers that matter least and it barely touches the number that matters the most.”

Tony Huge, 13:47

The blood draw timing trap

This is the section most people will want to rewind. Tony cites a 20-week training study in 675 people where blood was drawn twice: 24 hours after the last session and 72 hours after. At 24 hours triglycerides were down. At 72 they were back where they started. HDL had risen 3.6% and stayed up at both draws. Another study found trained and untrained people had the same triglycerides after about 60 hours off. So the HDL was 20 weeks of training; the triglyceride drop was the last workout wearing off. His conclusion is that a baseline triglyceride reading requires at least three days off hard training before the draw.

Diet gets the same treatment. Across 60 controlled-feeding trials, taking fat out and putting carbohydrate in raised triglycerides, about 2.2 points per 1% of calories swapped from saturated fat to carbs. A liter of regular cola a day for six months raised triglycerides 32% while milk, diet cola, and water did not, and sugar drinks doubled how fast the liver builds new fat, which is where fasting triglycerides mostly come from. Cutting carbs lowers triglycerides more than cutting fat, and raises LDL while doing it. What lowers triglycerides without a catch, per Tony’s reading: weight loss (about 11 points across 83 trials), swapping carbs for protein or unsaturated fat, and fish oil at 3.4 g a day, which cut them 27% where 0.85 g did nothing.

Which exercise, and why it protects you anyway

Tony cites a trial that assigned set distances at set speeds. Walking 12 miles a week at an easy pace cut triglycerides 40 points. Jogging the same 12 miles hard cut them 8. Jogging 20 miles hard cut them 24. Same distance, and the slow group beat the hard group five to one. HDL went the other way: the hardest, longest group gained three points and the walkers gained almost nothing. Across 25 trials, every extra 10 minutes per session raised HDL about 1.4 points while going harder did not, with a floor at 120 minutes a week and a ceiling around 265 where HDL starts giving it back.

Then he dismantles the HDL story itself. Drug companies spent 20 years and billions trying to raise HDL more than a workout could. One drug raised it 72% and heart attacks and deaths went up. One raised it 31 to 40% and nothing happened. One raised it 133% and cut LDL 31% and heart attacks were unchanged. The one that worked cut heart attacks 9% and lowered LDL 17 points, which Tony reads as the real cause. Exercise raises HDL about 2.5 points, 3 to 4%, not the 5 to 10% people repeat. Two things are true: exercise raises HDL, and the rise is not why it protects you. The protection runs through blood pressure, insulin, and the vessels themselves.

For LDL specifically, Tony cites a 53-trial comparison where lifting and lifting plus cardio were the only interventions that lowered it, about six points versus cardio’s half point. Diet plus cardio managed nine points. A statin, at 38.7 points and a 22% reduction in heart attacks, is in a different weight class. The claim that statins blunt training comes from one 37-person trial; a 420-person high-dose trial over six months found no strength loss.

Cheat Sheet Pivot

What Tony reported doing and what the cited trials used, not a prescription.

  • Tony’s practical floor is 120 minutes of exercise a week, mixing easy cardio like walking with hard, heavy work like lifting, because the trials show they move different numbers.
  • He draws blood at least three days after the last hard session when he wants a real triglyceride baseline.
  • He stopped drinking sugar, citing the cola trial and the liver’s role in fasting triglycerides.
  • He takes rosuvastatin at a low dose, not every day, at night, so it is less present during afternoon training.
  • Among the mimetics he graded: berberine has 14 trials in over 1,400 people (LDL down about 18 points, triglycerides down about 26); metformin lowered LDL about five points and triglycerides not at all, but cut all-cause death 36% over 11 years in overweight diabetics while blunting training gains in older adults; SR9011 has no human trials; MOTS-c is mouse-only; cardarine has one human trial showing a 30% triglyceride drop in two weeks alongside a cancer concern he says he has addressed elsewhere.
  • Tony reports that cardarine improved his lipids more than anything else during post-cycle and TRT phases, but was not strong enough to counteract a full bodybuilding cycle.

The full list of compounds Tony grades in this and other videos is in the Miracle Molecules Cheat Sheet. For the particle-count argument in depth, read ApoB vs LDL Cholesterol: The Number That Predicts Risk. For the berberine trial data and its interactions, see Berberine: What the Randomized Trials Show.

Where the evidence stops

Tony notes that a quarter to a third of how blood fats respond to training is genetic, and some people train for months and their cholesterol gets worse. Fasted cardio did nothing extra across 28 trials and raised glucose and insulin. The mimetic data is uneven: SR9011 kept working in mice even after researchers deleted the genes it was supposed to act through, so nobody knows its full mechanism, and cardarine’s single human trial says nothing about its long-term safety.

Most importantly, the video’s own thesis limits it. Exercise barely changes ApoB, and ApoB is what causes heart disease. Tony’s personal observation that his heart functions noticeably better when he trains is exactly that, an observation, and he attributes it to mechanisms other than cholesterol.

Keep going

For what Tony actually takes to manage lipids with his genetics, read My Cholesterol Protocol. Companion articles like this one arrive first through the tonyhuge.is email list, and the rest of the cardiovascular archive is at tonyhuge.is.

Popular Category